MAPT and Cognitive impairment: Many studies found a preeminent role of the Aβ/tau ratio in predicting cognitive impairment over time [79,97,98], and others described as the global CSF profile alteration at baseline, namely both pathological Aβ42 and tau values, holds the highest risk for conversion [84,98,99].